Over 72,000 women were diagnosed with cervical cancer and almost 34,000 died from this disease in the Region of the Americas, in 2018. Cervical cancer mortality rates are 3 times higher in Latin America and the Caribbean than in North America, highlighting inequities in health. Screening women for cervical pre-cancer, followed by treatment, is a cost-effective intervention to prevent cervical cancer. Vaccination against Human Papilloma Virus (HPV) can reduce significatively the risk of cervical cancer. PAHO recommends to vaccinate girls from 9 to 14 years-old, when it is more effective. HPV vaccines are available in 35 countries and territories of the Americas, but coverage rates with the two doses do not reach yet 80% of girls. Along with HPV vaccination, screening and treatment of precanceous lesions can prevent new cases and deaths.
This page has been archived and is no longer updated. We apologize for the inconvenience. To find similar material or an updated version of the page, please visit one the following resources:
Health Topics || Country Sites || News Releases || Our New Homepage
Esta página ha sido archivada y ya no es actualizada. Pedimos disculpas por la molestia. Para encontrar material similar o una versión actualizada de la página, visite uno de los siguientes recursos:
Temas de salud || Sitios de países || Comunicados de prensa || Nuestra nueva página de inicio
- 1-2 August, 2019.- Towards Elimination of Cervical Cancer in the Americas.
- 31 July-1 August, 2018.- Experiences in the implementation of cervical cancer screening programs based in HPV testing
Scientific and technical material: Cervical cancer
- Methodology to calculate HPV Vaccine Coverage in the Region of the Americas
- Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes (2019)